Insider Buy/Sell Details for the Biotechnology Industry — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (936)
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$16.08
Total Value
$241.20K
Shares Held After
2,290,379
% of Holdings
0.7%
Gemini Therapeutics, Inc. (GMTX)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
3,231
Price
$62.86
Total Value
$203.10K
Shares Held After
54,324
% of Holdings
5.6%
Gemini Therapeutics, Inc. (GMTX)
Quisel John D — Director
Shares
13,264
Price
$62.86
Total Value
$833.78K
Shares Held After
226,064
% of Holdings
5.5%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
3,256
Price
$62.86
Total Value
$204.67K
Shares Held After
92,589
% of Holdings
3.4%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
2,853
Price
$62.86
Total Value
$179.34K
Shares Held After
52,173
% of Holdings
5.2%
Gemini Therapeutics, Inc. (GMTX)
Stephenson Pamela — Chief Commercial Officer
Shares
5,531
Price
$62.86
Total Value
$347.68K
Shares Held After
80,998
% of Holdings
6.4%
Aura Biosciences, Inc. (AURA)
de los Pinos Elisabet — Director
Shares
47,648
Price
$5.06
Total Value
$241.10K
Shares Held After
409,815
% of Holdings
10.4%
Aura Biosciences, Inc. (AURA)
Hopkins Janet Jill — Chief Medical Officer
Shares
20,401
Price
$5.06
Total Value
$103.23K
Shares Held After
232,284
% of Holdings
8.1%
Aura Biosciences, Inc. (AURA)
Elazzouzi Amy — Senior Vice President, Finance
Shares
8,549
Price
$5.06
Total Value
$43.26K
Shares Held After
75,532
% of Holdings
10.2%
Aura Biosciences, Inc. (AURA)
Plavsic Mark — Chief Technology Officer
Shares
15,890
Price
$5.05
Total Value
$80.24K
Shares Held After
181,397
% of Holdings
8.1%
Aura Biosciences, Inc. (AURA)
Kilroy Conor — Chief Legal Officer and Secretary.
Shares
12,079
Price
$5.05
Total Value
$61.00K
Shares Held After
167,234
% of Holdings
6.7%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,876
Price
$0.64
Total Value
$1.21K
Shares Held After
218,618
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
220,494
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
222,136
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,032
Price
$0.64
Total Value
$3.24K
Shares Held After
443,404
% of Holdings
1.1%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,979
Price
$0.64
Total Value
$2.56K
Shares Held After
448,436
% of Holdings
0.9%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
5,851
Price
$0.64
Total Value
$3.76K
Shares Held After
452,415
% of Holdings
1.3%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
2,022
Price
$0.64
Total Value
$1.30K
Shares Held After
119,752
% of Holdings
1.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
836
Price
$0.64
Total Value
$537.88
Shares Held After
121,774
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
611
Price
$0.64
Total Value
$393.12
Shares Held After
122,610
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
2,041
Price
$331.96
Total Value
$677.53K
Shares Held After
21,264
% of Holdings
8.8%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$27.59
Total Value
$11.51K
Shares Held After
44,089
% of Holdings
0.9%
Avista Public Acquisition Corp. II (AHPA)
Berkman Charles S — Chief Legal Officer
Shares
6,990
Price
$1.70
Total Value
$11.88K
Shares Held After
383,623
% of Holdings
1.8%
Avista Public Acquisition Corp. II (AHPA)
GUSTAFSON KURT A — Executive VP, Finance and CFO
Shares
6,828
Price
$1.70
Total Value
$11.61K
Shares Held After
259,402
% of Holdings
2.6%
Avista Public Acquisition Corp. II (AHPA)
FOEHR MATTHEW W — Director
Shares
20,754
Price
$1.70
Total Value
$35.28K
Shares Held After
4,375,787
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
936
Price
$32.78
Total Value
$30.69K
Shares Held After
34,018
% of Holdings
2.7%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
6,064
Price
$32.30
Total Value
$195.87K
Shares Held After
34,954
% of Holdings
14.8%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$474.68
Total Value
$23.73K
Shares Held After
220
% of Holdings
18.5%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
89
Price
$8.47
Total Value
$753.83
Shares Held After
7,677
% of Holdings
1.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President
Shares
78
Price
$8.47
Total Value
$660.66
Shares Held After
7,789
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Young Teresa L. — EVP, Chief Commercial & Strategy Officer
Shares
75
Price
$8.47
Total Value
$635.25
Shares Held After
8,557
% of Holdings
0.9%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$8.47
Total Value
$2.19K
Shares Held After
11,577
% of Holdings
2.2%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
21,162
Price
$43.90
Total Value
$929.01K
Shares Held After
21,120
% of Holdings
50.0%
EXELIXIS, INC. (EXEL)
Oliver Bob — Director
Shares
9,088
Price
$43.61
Total Value
$396.33K
Shares Held After
42,282
% of Holdings
17.7%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
3,856
Price
$43.79
Total Value
$168.85K
Shares Held After
17,524
% of Holdings
18.0%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,278
Price
$43.00
Total Value
$1.47M
Shares Held After
1,042,579
% of Holdings
3.2%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
12,116
Price
$18.21
Total Value
$220.63K
Shares Held After
339,254
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Loomis David K — Chief Accounting Officer
Shares
1,016
Price
$11.89
Total Value
$12.08K
Shares Held After
30,800
% of Holdings
3.2%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
5,685
Price
$11.89
Total Value
$67.59K
Shares Held After
163,938
% of Holdings
3.4%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
4,592
Price
$11.89
Total Value
$54.60K
Shares Held After
151,232
% of Holdings
2.9%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,134
Price
$11.89
Total Value
$61.04K
Shares Held After
159,267
% of Holdings
3.1%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
4,403
Price
$11.89
Total Value
$52.35K
Shares Held After
154,482
% of Holdings
2.8%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
12,279
Price
$3.31
Total Value
$40.67K
Shares Held After
1,052,045
% of Holdings
1.2%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
3,726
Price
$3.31
Total Value
$12.34K
Shares Held After
92,176
% of Holdings
3.9%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
12,253
Price
$3.31
Total Value
$40.58K
Shares Held After
683,376
% of Holdings
1.8%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$26.49
Total Value
$5.30M
Shares Held After
1,654,597
% of Holdings
10.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
13,871
Price
$7.78
Total Value
$107.95K
Shares Held After
174,316
% of Holdings
7.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
57,952
Price
$1.31
Total Value
$75.88K
Shares Held After
1,443,641
% of Holdings
4.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
4,701
Price
$7.78
Total Value
$36.59K
Shares Held After
96,694
% of Holdings
4.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
1,500
Price
$499.99
Total Value
$749.99K
Shares Held After
46,132
% of Holdings
3.1%
Showing 451–500 of 936 transactions (page 10 of 19)